News | News By Subject | News by Disease News By Date | Search News

Head & neck cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Merck & Co. (MRK) Dealt Another Setback as Its Ace Keytruda Comes Up Short in Head and Neck Cancer Study     7/26/2017
AstraZeneca PLC (AZN) Faces Another R&D Setback as Plans to File for Early Approval for Cancer Med are Scrapped     11/10/2016
Bristol-Myers Squibb (BMY)’s Opdivo Tagged a Breakthrough by the FDA for Head and Neck Cancer     4/25/2016
Eagle Pharma (EGRX), Teikoku Pharma Win FDA Approval of Docetaxel Injection, First and Only Alcohol-Free Formulation     12/28/2015
Shares Jump as Foamix Pharma (FOMX)'s FDX104 Shows Efficacy in Phase II Study     12/3/2015
ASCO15 EXCLUSIVE: Onxeo Will Run Phase III Trial For Oral Mucositis By End of 2015, CEO Tells BioSpace (DHX)     5/29/2015
Eli Lilly (LLY) Snags North American Rights to Erbitux From Bristol-Myers Squibb (BMY)     4/16/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
AstraZeneca PLC (AZN) Steps Up Push Into Cancer Immunotherapy, Falls Behind Rivals Such As Bristol-Myers Squibb Company (BMY), Merck & Co., Inc. (MRK), And Roche (RHHBY)     7/31/2014
Merck & Co., Inc. (MRK) Immune System-Booster MK3475 Effective In Skin, Lung Cancer     6/2/2014
Navidea Biopharmaceuticals (NAVB) Reports Positive Top-Line Results From Interim Analysis of Lymphoseek     4/4/2013
FDA Approves Bristol-Myers Squibb Company (BMY)'s Erbitux to Treat Late-stage Head and Neck Cancer     11/8/2011
Eli Lilly and Company (LLY) Drops Alimta in Head/Neck Cancer After Failing Phase 3 Trial     10/12/2010

News from Around the Web
FDA Requests More Changes On The Clinical Hold Of CEL-SCI (CVM)'s Head And Neck Cancer Trial     6/30/2017
Gazing Into The Crystal Ball For Advaxis (ADXS): What To Expect At ASCO 2017     4/7/2017
Stanford University Scientists Look Deeper Into The Body With New Fluorescent Dye     12/29/2015
Compound In Magnolia May Combat Head And Neck Cancers, University of Alabama at Birmingham Study     6/29/2015
Broccoli Sprout May Prevent Head and Neck Cancer, University of Pittsburgh Cancer Institute (UPCI) Study     4/20/2015
How Red Wine Prevents Cancer, University of Colorado Study     12/5/2014
Novel Biomarker For Head And Neck Cancer, Lung Cancer Identified, The Scripps Research Institute Study     4/4/2014
Common Genetic Alteration Found in Head and Neck Cancers May Not be Key to Effective Treatment, Cancer Research Reveals     1/30/2013
Rise in Some Head and Neck Cancers Tied to Oral Sex: University of Wisconsin Study     1/26/2011
Genetic Ancestry: A New Look at Racial Disparities in Head and Neck Cancer, Henry Ford Hospital Study     9/27/2010
Sex Virus Blamed For Rise In Head And Neck Cancers, University Hospital Coventry Study     3/29/2010
Henry Ford Hospital Study Finds 231 New Genes Associated With Head And Neck Cancer     10/5/2009
Curcumin May Inhibit Nicotine-induced Activation Of Head And Neck Cancers, Study Presented At American Academy of Otolaryngology Conference     10/5/2009
University of Pennsylvania School of Medicine Researchers Identify Natural Tumor Suppressor     9/11/2008
Tooth Loss Strongly Linked To Risk Of Esophageal, Head And Neck, And Lung Cancer, Aichi Cancer Center and Nagoya University Study     5/14/2008

Press Releases
Soligenix (SNGX) Announces $1.5 Million NIDCR SBIR Grant Award Supporting The Pivotal Phase III Clinical Trial Of SGX942 For The Treatment Of Oral Mucositis In Head And Neck Cancer     9/20/2017
Crown Bioscience’s Integrated Oncology Platform Helps Advance Apogenix’s Promising HERA-GITRL Immunotherapy For NSCLC And Head And Neck Cancer     9/13/2017
Ionis Pharma (IONS) Release: New Data Presented At European Society For Medical Oncology Meeting Demonstrate Antitumor Activity With IONIS-STAT3-2.5 Rx In Combination With Imfinzi     9/11/2017
Kura Oncology Rockets On Phase II Head And Neck Cancer Data     9/8/2017
CEL-SCI (CVM) Rockets As The FDA Removes Hold On Phase III Head & Neck Cancer Trial     8/14/2017
FDA Removes Clinical Hold On CEL-SCI (CVM)’s Phase III Head & Neck Cancer Trial     8/14/2017
Galera Announces Promising Innovative Medicines Designation From The United Kingdom’s Medicines And Healthcare Products Regulatory Agency For GC4419 For The Reduction Of Oral Mucositis In Head And Neck Cancer Patients     7/31/2017
Soligenix (SNGX) Initiates Pivotal Phase III Clinical Trial Of SGX942 (Dusquetide) For The Treatment Of Oral Mucositis In Head And Neck Cancer Patients     7/27/2017
Accuray Inc. (ARAY) Release: New Data Show TomoTherapy System Superior To RapidArc in Achieving Local Control Of Head And Neck Cancers     7/20/2017
PDS Biotechnology Corporation Announces Clinical Collaboration With Merck & Co. (MRK) To Evaluate Combination Of Versamune PDS0101 And KEYTRUDA (Pembrolizumab) For Metastatic Head And Neck Cancer     7/10/2017
Debiopharm Announces Completion Of Enrollment In Phase I/II Clinical Trial With Debio 1143 In SCCHN     6/15/2017
Hitachi (HIT) And MD Anderson Cancer Center To Collaborate In Research For Treatment Of Oropharyngeal Cancer Of The Head And Neck     6/7/2017
Boston Biomedical Presents Data For Investigational Stemness Inhibitor Amcasertib At ASCO 2017     6/6/2017
CEL-SCI (CVM) Submits FDA Response For Its Phase III Head And Neck Cancer Trial     6/5/2017
Incyte (INCY) Release: Clinical Trial Data For Combination Of Epacadostat And Opdivo (Nivolumab) Demonstrate Durable Clinical Responses In Patients With Melanoma And Head And Neck Cancer     6/5/2017